IDYA vs. IR
IDYA (IDEAYA Biosciences, Inc.) and IR (Ingersoll-Rand Plc) are both stocks. IDYA operates in Biotechnology (Healthcare), while IR operates in Specialty Industrial Machinery (Industrials). Over the past 5 years, IDYA returned 13.86%/yr vs 10.45%/yr for IR. At a 0.23 correlation, their price movements are largely independent.
Performance
IDYA vs. IR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDYA achieves a 4.57% return, which is significantly higher than IR's -0.78% return.
IDYA
- 1D
- -2.27%
- 1M
- 24.74%
- 6M
- -1.87%
- YTD
- 4.57%
- 1Y
- 60.81%
- 3Y*
- 16.83%
- 5Y*
- 13.86%
- 10Y*
- —
IR
- 1D
- -0.37%
- 1M
- 6.16%
- 6M
- -8.65%
- YTD
- -0.78%
- 1Y
- -11.66%
- 3Y*
- 6.02%
- 5Y*
- 10.45%
- 10Y*
- —
IDYA vs. IR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IDYA IDEAYA Biosciences, Inc. | 4.57% | 34.51% | -27.77% | 95.82% | -23.14% | 68.86% | 86.67% | -46.43% |
IR Ingersoll-Rand Plc | -0.78% | -12.34% | 17.06% | 48.21% | -15.41% | 35.85% | 24.21% | 8.31% |
Correlation
The correlation between IDYA and IR is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since May 23, 2019 | 0.23 |
The correlation between IDYA and IR shifts across timeframes, from 0.20 (1 year) to 0.30 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
IDYA:
$3.44B
IR:
$30.74B
IDYA:
-$1.57
IR:
$2.21
IDYA:
14.28
IR:
2.68
IDYA:
$225.27M
IR:
$7.78B
IDYA:
$215.25M
IR:
$2.98B
IDYA:
-$157.90M
IR:
$1.55B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDYA vs. IR — Risk / Return Rank
IDYA
IR
IDYA vs. IR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Ingersoll-Rand Plc (IR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IDYA | IR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.58 | ||
| Sortino ratioReturn per unit of downside risk | +2.16 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.97 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 2.26 | -0.38 | +2.64 |
| Martin ratioReturn relative to average drawdown | 4.98 | -0.82 | +5.79 |
Loading charts...
Drawdowns
IDYA vs. IR - Drawdown Comparison
The maximum IDYA drawdown since its inception was -78.36%, which is greater than IR's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for IDYA and IR.
Loading charts...
Drawdown Indicators
| IDYA | IR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.36% | -50.27% | -28.09% |
Max Drawdown (1Y)Largest decline over 1 year | -27.10% | -30.56% | +3.46% |
Max Drawdown (3Y)Largest decline over 3 years | -69.23% | -36.62% | -32.61% |
Max Drawdown (5Y)Largest decline over 5 years | -69.42% | -36.62% | -32.80% |
Current DrawdownCurrent decline from peak | -23.30% | -25.32% | +2.02% |
Average DrawdownAverage peak-to-trough decline | -32.28% | -12.93% | -19.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.26% | 14.58% | -2.32% |
Volatility
IDYA vs. IR - Volatility Comparison
IDEAYA Biosciences, Inc. (IDYA) has a higher volatility of 15.27% compared to Ingersoll-Rand Plc (IR) at 9.18%. This indicates that IDYA's price experiences larger fluctuations and is considered to be riskier than IR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDYA | IR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.27% | 9.18% | +6.09% |
Volatility (6M)Calculated over the trailing 6-month period | 36.23% | 25.71% | +10.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.45% | 34.02% | +15.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.74% | 30.16% | +28.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.17% | 34.33% | +39.84% |
Dividends
IDYA vs. IR - Dividend Comparison
IDYA has not paid dividends to shareholders, while IR's dividend yield for the trailing twelve months is around 0.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDYA IDEAYA Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IR Ingersoll-Rand Plc | 0.10% | 0.10% | 0.09% | 0.10% | 0.15% | 0.03% | 0.00% | 5.78% |
Financials
IDYA vs. IR - Financials Comparison
This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and Ingersoll-Rand Plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IDYA and IR have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDYA has higher volatility (15.27%) compared to IR (9.18%). In terms of maximum drawdown, IDYA dropped -78.36% vs IR's -50.27%.
IDYA currently has the higher Sharpe Ratio (1.24 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDYA and IR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer